Using Virtual Reality Travel to Reduce Loneliness in Older Adults (VRT)
Virtual Reality Travel (VRT) as a Loneliness Intervention for Older Adults: A Pilot Randomized Controlled Trial
This study aims to investigate whether and how virtual reality travel (VRT) can reduce loneliness among older adults. It will utilize a mixed-methods research design that combines an randomly assigned experiment with follow-up semi-structured interviews.
This is a pilot study and it is essential to establish the feasibility and acceptability of the protocol, assess the tolerability of VR technology in this population prior to conducting a full-scale RCT, and generate preliminary effect size estimates to inform future sample size calculations.
Aperçu de l'étude
Statut
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Ruiping Ren
- Numéro de téléphone: 812-671-4087
- E-mail: renruip@iu.edu
Lieux d'étude
-
-
Indiana
-
Bloomington, Indiana, États-Unis, 47401
- Recrutement
- Evergreen Village at Bloomington
-
Contact:
- Sherri Ganka
- Numéro de téléphone: 812-336-2718
- E-mail: resident.services@evergreenvillage-bloomington.com
-
Bloomington, Indiana, États-Unis, 47408
- Recrutement
- Bell Trace
-
Contact:
- Melissa Davis
- Numéro de téléphone: 812-332-2355
- E-mail: mdavis@cardon.us
-
Ellettsville, Indiana, États-Unis, 47429
- Recrutement
- Area 10 Agency on Aging
-
Contact:
- Amy Guerrettaz
- Numéro de téléphone: 812-935-2582
- E-mail: aguerrettaz@area10agency.org
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte plus âgé
Accepte les volontaires sains
La description
Inclusion Criteria:
- Adults aged 65 years or older
- Express willingness to engage with VR technology
Exclusion Criteria:
- No self-reported physical, sensory, neurological, or cognitive conditions that would make VR use unsafe or impractical (e.g., uncontrolled seizures, severe vertigo, or significant uncorrected vision/hearing impairments).
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Virtual reality travel group
Participants in the VR travel group experience a 13-minute-and-44-second VR tour of Bali Island, Indonesia.
|
Participants in the VR travel group experience a 13-minute-and-44-second VR tour of Bali Island, Indonesia.
|
|
Comparateur actif: Attention control group
Participants in the attention control group complete 13-minute-and-44-second symmetric puzzles featuring leaves, birds, and insects.
|
Participants in the attention control group complete 13 minutes and 44 seconds symmetric puzzles featuring leaves, birds, and insects.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
loneliness
Délai: Baseline and following completion of the intervention session (approximately 20-30 minutes after baseline assessment)
|
Loneliness was assessed using a multi-item visual analog scale (VAS), with items presented as 100 mm horizontal lines anchored by "Not at all" (left) and "Extremely" (right). Items were adapted from the University of California, Los Angeles Loneliness Scale and modified to capture present-moment experience using a "Right now…" stem, enabling assessment of state-level rather than trait-level loneliness. Participants were instructed to indicate their current feelings by placing a single perpendicular mark on each line corresponding to their response. VAS scores were calculated by measuring the distance in millimeters from the left anchor to the participant's mark, yielding a continuous score ranging from 0 to 100 for each item. Item scores were then averaged to compute an overall loneliness score, with higher values indicating higher levels of state loneliness. |
Baseline and following completion of the intervention session (approximately 20-30 minutes after baseline assessment)
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
positive emotions
Délai: Baseline and following completion of the intervention session (approximately 20-30 minutes after baseline assessment)
|
Positive emotions was assessed using the Positive and Negative Affect Schedule (PANAS).
The PANAS consists of 20 items, including 10 items measuring positive affect (e.g., interested, excited, enthusiastic) and 10 items measuring negative affect (e.g., distressed, upset, nervous).
Participants were asked to indicate the extent to which they were experiencing each emotion right now on a Likert-type scale ranging from 1 (Very slightly or not at all) to 5 (Extremely), consistent with the state version of the measure.
Scores for positive affect and negative affect were computed separately by averaging the corresponding items, with higher scores indicating greater levels of the respective emotional state.
|
Baseline and following completion of the intervention session (approximately 20-30 minutes after baseline assessment)
|
|
meaning in life
Délai: Baseline and following completion of the intervention session (approximately 20-30 minutes after baseline assessment)
|
Meaning in life was assessed using a modified version of the Multidimensional Existential Meaning Scale.
To capture state meaning in life, the phrase "right now" was added to each item to reflect participants' momentary perceptions.
The MEMS is a 15-item multidimensional measure based on a tripartite conceptualization of meaning in life encompassing comprehension (life coherence), purpose (goal-directedness), and mattering (perceived significance).
Participants rated each item on a 7-point Likert scale ranging from 1 (very strongly disagree) to 7 (very strongly agree).
Each subscale consists of five items, and subscale scores were computed by averaging corresponding items, with one mattering item reverse scored.
Higher scores indicate greater levels of comprehension, purpose, and mattering.
|
Baseline and following completion of the intervention session (approximately 20-30 minutes after baseline assessment)
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- IUB-VRTPilot-2026
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .